Linked Life Data

18028764

Source:http://linkedlifedata.com/resource/pubmed/id/18028764

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
20
pubmed:dateCreated
2007-11-21
pubmed:abstractText
Chemotherapy is the most frequently adopted adjuvant therapy of pancreatic ductal adenocarcinoma (PDAC), but the development of drug resistance reduces its effectiveness. Clarification of the mechanism of multidrug resistance (MDR) development in PDAC is needed to improve the therapeutic effect of chemotherapy. This study was aimed to investigate the molecular mechanism of MDR of PDAC and to identify genes associated with MDR development.
pubmed:commentsCorrections
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Oct
pubmed:issn
0366-6999
pubmed:author
pubmed:issnType
Print
pubmed:day
20
pubmed:volume
120
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1743-52
pubmed:dateRevised
2011-10-14
pubmed:meshHeading
pubmed:year
2007
pubmed:articleTitle
Microarray analysis of gene expression profile of multidrug resistance in pancreatic cancer.
pubmed:affiliation
Department of General Surgery, Chinese Academy of Medical Sciences and Peking Union Medical College Hospital, Beijing 100730, China. zhao8028@yahoo.com.cn
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't